Archives

The beta-blocker controversy: New evidence from the CHARISMA trials

Ever since beta-blockers were pharmaceutically introduced, there loomed a cloud of doubt over their therapeutic safety.  Whether beta-blockers can be used liberally for a range of cardiovascular diseases or not has been a persistent question for physicians and cardiologists across the globe. Though research supports the use of beta-blockers in patients with a history of …

The Triclosan controversy: An overview for doctors

Triclosan is a chlorinated organic compound known for its antibacterial and antifungal properties, and is used widely in consumer products such as soaps, detergents and toothpastes. Interestingly, it is approved and registered by the U.S Environmental and Protection Agency as a pesticide. Of late, its widespread use in consumer products has caused serious health concerns …